Health U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease James Pereira Dec 10, 2023 The U.S. Food and Drug Administration on Friday approved the country's first gene-editing treatment, Casgevy, for use in… Read More...
Health CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting James Pereira Mar 15, 2023 <!-- Name:DistributionId Value:8788444 --> <!--… Read More...
Health CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial… James Pereira Feb 22, 2023 <!-- Name:DistributionId Value:8753889 --> <!--… Read More...
Health CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted… James Pereira Sep 29, 2022 ZUG, Switzerland and BOSTON, Sept. 28, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a… Read More...
Health CRISPR Therapeutics Presents Positive Results from its Phase 1 COBALT™-LYM Trial of CTX130™ in… James Pereira Jun 11, 2022 -70% overall response rate (ORR) and 30% complete response (CR) rate in peripheral T-cell lymphoma (PTCL) and cutaneous… Read More...
Health Stem cells may finally offer a cure for Type 1 diabetes James Pereira Mar 26, 2022 There are 537 million people around the world living with diabetes. And that number is growing. When people have Type 1… Read More...
Health CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted… James Pereira Nov 23, 2021 ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a… Read More...
Health CRISPR gene-editing treatment could reach patients ‘very, very soon’: Intellia CEO James Pereira Jul 3, 2021 Following a breakthrough trial where gene-editing technology CRISPR completed its first systematic delivery as medicine… Read More...
Health How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer… James Pereira Jul 1, 2021 Gene-editing technology CRISPR reached a major milestone this past weekend, completing its first systemic delivery as a… Read More...